sharon osborne, chelsea handler and elon musk have publicly talked about taking the drug and it has further backing from oprah winfrey. it is a global phenomenon reaching millions on social media. but it is not without controversy, including possible side effects, high prices, and the company's lobbying efforts receiving criticism around the world. in some cases, patients might also need to take the drug indefinitely to avoid regaining the weight. the chief executive says obesity is a disease and thinks the company will learn from its growing number of patients. >> my view is we will hear the patients are much different. we will have to build a portfolio. >> on this episode of leaders will block well, i travel to the in copenhagen and ask him about the global sensation, how he is navigating the companies. thank you for being on bloomberg with us. after decades of research, a molecule that changes everything in terms of weight loss drugs. were you taken by surprise at the appetite for the drugs and how mainstream they are? >> the main surprise is when you get product like that, it starts wit